title: Pemetrexed-induced skin sclerosis.
authors.forename: C
authors.initials: C
authors.lastname: Merklen-Djafri
authors.forename: E
authors.initials: E
authors.lastname: Imbert
authors.forename: D
authors.initials: D
authors.lastname: Courouge-Dorcier
authors.forename: R
authors.initials: R
authors.lastname: Schott
authors.forename: J-P
authors.initials: JP
authors.lastname: Méraud
authors.forename: C
authors.initials: C
authors.lastname: Muller
authors.forename: M
authors.initials: M
authors.lastname: Tebacher
authors.forename: G
authors.initials: G
authors.lastname: Springinsfeld
authors.forename: B
authors.initials: B
authors.lastname: Cribier
authors.forename: D
authors.initials: D
authors.lastname: Lipsker
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D005971:Glutamates / Q000008:administration & dosage / Q000009:adverse effects*; D006147:Guanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000068437:Pemetrexed; D012598:Sclerosis / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine